BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9879829)

  • 21. Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine.
    Adachi Y; Tamiya T; Ichikawa T; Terada K; Ono Y; Matsumoto K; Furuta T; Hamada H; Ohmoto T
    Hum Gene Ther; 2000 Jan; 11(1):77-89. PubMed ID: 10646641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration.
    Koyama F; Sawada H; Fujii H; Hirao T; Ueno M; Hamada H; Nakano H
    J Exp Clin Cancer Res; 2000 Mar; 19(1):75-80. PubMed ID: 10840940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
    Zhang J; Wei F; Wang H; Li H; Qiu W; Ren P; Chen X; Huang Q
    Cancer Biother Radiopharm; 2010 Aug; 25(4):487-95. PubMed ID: 20735209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase.
    Chung-Faye GA; Chen MJ; Green NK; Burton A; Anderson D; Mautner V; Searle PF; Kerr DJ
    Gene Ther; 2001 Oct; 8(20):1547-54. PubMed ID: 11704815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory.
    Consalvo M; Mullen CA; Modesti A; Musiani P; Allione A; Cavallo F; Giovarelli M; Forni G
    J Immunol; 1995 May; 154(10):5302-12. PubMed ID: 7730633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene.
    Erbs P; Regulier E; Kintz J; Leroy P; Poitevin Y; Exinger F; Jund R; Mehtali M
    Cancer Res; 2000 Jul; 60(14):3813-22. PubMed ID: 10919655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene.
    Shen LZ; Wu WX; Xu DH; Zheng ZC; Liu XY; Ding Q; Hua YB; Yao K
    World J Gastroenterol; 2002 Apr; 8(2):270-5. PubMed ID: 11925606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma.
    Topf N; Worgall S; Hackett NR; Crystal RG
    Gene Ther; 1998 Apr; 5(4):507-13. PubMed ID: 9614575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect.
    Pierrefite-Carle V; BaquƩ P; Gavelli A; Mala M; Chazal M; Gugenheim J; Bourgeon A; Milano G; Staccini P; Rossi B
    J Natl Cancer Inst; 1999 Dec; 91(23):2014-9. PubMed ID: 10580026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenovirus mediated cytosine deaminase gene transduction and 5-fluorocytosine therapy sensitizes mouse prostate cancer cells to irradiation.
    Anello R; Cohen S; Atkinson G; Hall SJ
    J Urol; 2000 Dec; 164(6):2173-7. PubMed ID: 11061950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
    Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
    Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of gene therapy with the herpes simplex virus thymidine kinase gene and the bacterial cytosine deaminase gene for the treatment of hepatocellular carcinoma.
    Kuriyama S; Mitoro A; Yamazaki M; Tsujinoue H; Nakatani T; Akahane T; Toyokawa Y; Kojima H; Okamoto S; Fukui H
    Scand J Gastroenterol; 1999 Oct; 34(10):1033-41. PubMed ID: 10563675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Yamaue H; Tanimura H
    Cancer Res; 2001 Aug; 61(16):6158-62. PubMed ID: 11507067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential benefits of combining cytosine deaminase/5-fluorocytosine gene therapy and irradiation for prostate cancer: experimental study.
    Kato H; Koshida K; Yokoyama K; Mizokami A; Namiki M
    Int J Urol; 2002 Oct; 9(10):567-76. PubMed ID: 12445236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective in vivo radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells transduced with the E. coli cytosine deaminase (CD) gene.
    Gabel M; Kim JH; Kolozsvary A; Khil M; Freytag S
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):883-7. PubMed ID: 9652853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anticancer effects of cytosine deaminase gene/5-fluorocytosine therapies to ovarian cancer in vivo].
    Yao Y; Peng Z; Wang H; Li Q; Liu S
    Zhonghua Fu Chan Ke Za Zhi; 2002 Apr; 37(4):195-7. PubMed ID: 12133407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine.
    Crystal RG; Hirschowitz E; Lieberman M; Daly J; Kazam E; Henschke C; Yankelevitz D; Kemeny N; Silverstein R; Ohwada A; Russi T; Mastrangeli A; Sanders A; Cooke J; Harvey BG
    Hum Gene Ther; 1997 May; 8(8):985-1001. PubMed ID: 9195221
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experimental study on human pancreatic carcinoma treated by cytosine deaminase gene therapy].
    Zhang S; Yuan S
    Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):249-51. PubMed ID: 11798763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine.
    Hirschowitz EA; Ohwada A; Pascal WR; Russi TJ; Crystal RG
    Hum Gene Ther; 1995 Aug; 6(8):1055-63. PubMed ID: 7578418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
    Xie Y; Gilbert JD; Kim JH; Freytag SO
    Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.